MedPath

Allogeneic Bone Marrow and Mesenchymal Stem Cell Transplantation for patients with severe Hypophosphatasia

Phase 2
Conditions
Hypophosphatasia
Registration Number
JPRN-UMIN000003828
Lead Sponsor
Shimane University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

1. Objective Patients with non-severe HPP Patients wothuout inclusion criteria 2. BM donor Patients wothuout inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rescuing the patients with severe hypophospatasia
Secondary Outcome Measures
NameTimeMethod
Height, Weight, alkaline phosphatase(ALP), bone-type ALP, Ca, P, substrates of ALP(phosphoethanolamine, pyridoxal 5-phosphate), Neutrohpil ALP score, X-ray of bone and chest, bone density, ability of bone formation
© Copyright 2025. All Rights Reserved by MedPath